stocknshares
- A Delaware federal court issued final judgment in favor of TwinStrand BioSciences and the University of Washington, who accused Guardant Health (GH) of infringing two core patents related to TwinStrand’s Duplex Sequencing technology.
- The court upheld a jury’s $83.4M award for
